Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam
- 1 September 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 28 (3) , 425-427
- https://doi.org/10.1128/aac.28.3.425
Abstract
The pharmacokinetics of the monobactam carumonam (Ro 17-2301) as derived from serial measurement of the concentrations of this agent in serum, blister fluid, and urine were studied in six male volunteers subsequent to intravenous infusion of a single 2-g dose. Drug levels in serum in excess of 75 micrograms/ml were achieved 0.5 h after the end of infusion, declining to 2.9 micrograms/ml at 8 h. The mean serum and blister fluid elimination half-lives were 1.68 and 1.7 h, respectively. The urinary recovery of the drug by 24 h was 80.6% (range, 68.3 to 91.1%). Carumonam penetrated blister fluid well, the mean percentage penetration (as measured by the ratio of areas under curves) being 101.6%.This publication has 5 references indexed in Scilit:
- The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1985
- Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humansAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of azthreonamAntimicrobial Agents and Chemotherapy, 1982
- Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjectsJournal of Antimicrobial Chemotherapy, 1981
- The Influence of Protein Binding upon Tissue Fluid Levels of Six -Lactam AntibioticsThe Journal of Infectious Diseases, 1980